#	Pagina
attuale pagina	/open-h2020/projects/204368/index.html

Opendata, web and dolomites

Galastick

A medical device determining the daily amount of breast milk to improve neonatal nutrition andmothers’ psychophysics well-being.

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Galastick project word cloud

Explore the words cloud of the Galastick project. It provides you a very rough idea of what is the project "Galastick" about.

absence player feel donor babies plan starts psychological human excess integration device supervised assessing galastick milk infants midwiferies lateral people frequent nutrition warning confidence improves disposable active volunteer uses analyte preliminary engineer stick depression market trl reveals few samples immunochromatographic lactation deep reached nervousness commercialization 150 biological neonatal prototype detecting galascreen inadequate undermining medically simply onset health amount feeding industrialize reduce works pharma omini certifications diversity preterm successfully breastmilk colic mothers progressively occurs crying chain daily tested breastfeed regulatory newborn assay donate business flow hospitals lack sme mother medical breastfeeding proprietary screened strategy certified company wellness

Project "Galastick" data sheet

The following table provides information about the project.

Coordinator	GALASCREEN SRLS Organization address address: VIA SAVINIO ED. POLIFUNZIONALE DIPTO DI FARM city: RENDE postcode: 87036 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Italy [IT]
Project website	http://talentlab.calabriainnova.it/galascreen/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.6. (SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2016
Duration (year-month-day)	from 2016-06-01 to 2016-09-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	GALASCREEN SRLS GALASCREEN SRLS Organization address address: VIA SAVINIO ED. POLIFUNZIONALE DIPTO DI FARM city: RENDE postcode: 87036 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (RENDE)	coordinator	50˙000.00
2	OMINI PHARMA SOCIETA A RESPONSABILITA LIMITATA SEMPLIFICATA OMINI PHARMA SOCIETA A RESPONSABILITA LIMITATA SEMPLIFICATA Organization address address: PIAZZA CAVOUR 5 city: BUSSERO MILANO postcode: 20060 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (BUSSERO MILANO)	participant	0.00

Map

Project objective

'Biological diversity among people, reveals that not all mothers are the same. For some of them (not a few) it occurs that they are not able to successfully breastfeed their babies. Breastfeeding without 'feeding' can cause frequent crying and colic in the newborn and nervousness in mothers, lack of confidence in their abilities and depression. A mother starts to feel inadequate, undermining her psychological wellness. On the other hand, several mothers have breastmilk in excess and could donate it to preterm infants in midwiferies, thus promoting the babies' health and reduce hospitals' costs. Galascreen developed a proprietary disposable medical device, GalaStick, determining the lactation onset and the progressively increasing daily amount of breastmilk. The stick uses a lateral flow immunochromatographic assay that works simply detecting the presence (or absence) of a target analyte in the human milk sample. Such an easy to use stick not only improves the neonatal nutrition (warning if any feeding integration is needed), but also the psychological well-being of the mother. GalaStick has reached TRL 6 since a preliminary prototype has been tested with real human milk samples. More than 150 volunteer mothers and human milk donor mothers were successfully screened. Galascreen requires funding to engineer and industrialize the stick prototype and to get it medically certified as a medical device. Both key processes will be supervised and supported by the SME partner Omini Pharma. Phase 1 project will address a deep study on business development strategy and will define the value chain and the commercialization plan, together with assessing the regulatory procedures and certifications to be obtained by both the product and the company in order to be an active player on the medical market.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GALASTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GALASTICK" are provided by the European Opendata Portal: CORDIS opendata.